Northern Survey on Therapeutic Oxygen Prescription

Last updated: August 6, 2019
Sponsor: Hannover Medical School
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT03937622
Pneumo-O2
  • Ages > 18
  • All Genders

Study Summary

This is a prospective multicenter observational trial. Included patients and attending physician complete a standardized questionnaire.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with chronic lung disease, age > 18 years

  • Established domiciliary LTOT > 4 weeks

  • Scheduled for control of oxygen therapy with arterial/capillary

Exclusion

Exclusion Criteria:

  • No informed consent

  • Pulmonary exacerbation within the last 2 weeks

  • Signs of heart failure (edema, congestion)

Study Design

Total Participants: 500
Study Start date:
July 02, 2019
Estimated Completion Date:
September 20, 2021

Connect with a study center

  • Dep. Respiratory Medicine, Hannover Medical School

    Hannover, 30625
    Germany

    Active - Recruiting

  • Department of Respiratory Medicine, Medizinische Hochschule Hannover

    Hannover, 30625
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.